




Searching News Database: End Stage Renal Disease
HSMN NewsFeed - 11 Oct 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
HSMN NewsFeed - 11 Feb 2019
Fresenius Medical Care North America Launches 2008T BlueStar(TM) Hemodialysis Machine Across the U.S.
Fresenius Medical Care North America Launches 2008T BlueStar(TM) Hemodialysis Machine Across the U.S.
HSMN NewsFeed - 10 Oct 2016
Teleflex Receives FDA Clearance for ARROW(R)JACC with Chlorag+ard(R) Technology and Tunneler
Teleflex Receives FDA Clearance for ARROW(R)JACC with Chlorag+ard(R) Technology and Tunneler
HSMN NewsFeed - 7 Jun 2016
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
HSMN NewsFeed - 16 Oct 2013
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
HSMN NewsFeed - 22 Feb 2011
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
HSMN NewsFeed - 12 Aug 2010
First Patient Implanted in Investigational Study for Self Sealing GORE(R) ACUSEAL Vascular Graft
First Patient Implanted in Investigational Study for Self Sealing GORE(R) ACUSEAL Vascular Graft
HSMN NewsFeed - 2 Mar 2010
NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
HSMN NewsFeed - 3 Feb 2010
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
HSMN NewsFeed - 18 Dec 2009
Xcorporeal Announces Signing Agreement for the Sale of Substantially All of Its Assets
Xcorporeal Announces Signing Agreement for the Sale of Substantially All of Its Assets
HSMN NewsFeed - 8 Oct 2008
Xcorporeal, Inc. Appoints Kelly J. McCrann as Chairman and Chief Executive Officer
Xcorporeal, Inc. Appoints Kelly J. McCrann as Chairman and Chief Executive Officer
HSMN NewsFeed - 12 Aug 2008
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
HSMN NewsFeed - 17 Apr 2008
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
HSMN NewsFeed - 17 Mar 2008
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 17 Dec 2007
Prestigious Medical Journal Publishes Data on Xcorporeal's Wearable Artificial Kidney
Prestigious Medical Journal Publishes Data on Xcorporeal's Wearable Artificial Kidney
HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
HSMN NewsFeed - 10 Apr 2007
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
HSMN NewsFeed - 4 Apr 2007
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
HSMN NewsFeed - 2 Feb 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
HSMN NewsFeed - 29 Jan 2007
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Additional items found! 41

Members Archive contains
41 additional stories matching:
End Stage Renal Disease
(Password required)
End Stage Renal Disease
(Password required)